Phillip Eric Lee

Phillip Eric Lee

No open positions remaining

Net worth: 382 129 $ as of 30/06/2026

39 year
Health Technology
Consumer Services
Finance

Profile

Phillip Eric Lee formerly worked at Cytokinetics, Inc., as Senior Director from 2015 to 2018, Adverum Biotechnologies, Inc., as Associate Director from 2015 to 2016, 4D Molecular Therapeutics, Inc., as Senior Director & Vice President from 2018 to 2021, Vaxart, Inc., as Chief Financial & Accounting Officer from 2022 to 2025, Centerview Partners LLC, as Principal from 2009 to 2015, and Clover Biopharmaceuticals Ltd., as Chief Financial & Business Development Officer.
Mr. Lee received his undergraduate degree from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
24/03/2025 631,619 ( 0.26% ) 382 129 $ 30/06/2026

Former positions of Phillip Eric Lee

CompaniesPositionEnd
VAXART, INC. Director of Finance/CFO 19/05/2025
CLOVER BIOPHARMACEUTICALS, LTD. Director of Finance/CFO 01/07/2022
4D MOLECULAR THERAPEUTICS, INC. Director/Board Member 01/01/2021
CYTOKINETICS, INCORPORATED Director/Board Member 01/03/2018
ADVERUM BIOTECHNOLOGIES, INC. Corporate Officer/Principal 01/01/2016
See the detail of Phillip Eric Lee's experience

Training of Phillip Eric Lee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Phillip Eric Lee